180 related articles for article (PubMed ID: 38721172)
21. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
GBD 2021 Causes of Death Collaborators
Lancet; 2024 May; 403(10440):2100-2132. PubMed ID: 38582094
[TBL] [Abstract][Full Text] [Related]
22. Excess Mortality From Suicide During the Early COVID-19 Pandemic Period in Japan: A Time-Series Modeling Before the Pandemic.
Anzai T; Fukui K; Ito T; Ito Y; Takahashi K
J Epidemiol; 2021 Feb; 31(2):152-156. PubMed ID: 33310986
[TBL] [Abstract][Full Text] [Related]
23. Expression of Concern: Increased Age-Adjusted Cancer Mortality After the Third mRNA-Lipid Nanoparticle Vaccine Dose During the COVID-19 Pandemic in Japan.
Gibo M; Kojima S; Fujisawa A; Kikuchi T; Fukushima M
Cureus; 2024 Jun; 16(6):x58. PubMed ID: 38873395
[No Abstract] [Full Text] [Related]
24. Effects of the COVID-19 pandemic on the rates of adverse birth outcomes and fetal mortality in Japan: an analysis of national data from 2010 to 2022.
Tasuku O; Naoki N
BMC Public Health; 2024 May; 24(1):1430. PubMed ID: 38807097
[TBL] [Abstract][Full Text] [Related]
25. Different patterns of excess all-cause mortality by age and sex in Hungary during the 2
Fazekas-Pongor V; Szarvas Z; Nagy ND; Péterfi A; Ungvári Z; Horváth VJ; Mészáros S; Tabák AG
Geroscience; 2022 Oct; 44(5):2361-2369. PubMed ID: 35864376
[TBL] [Abstract][Full Text] [Related]
26. Trends of Cancer Screenings, Diagnoses, and Mortalities During the COVID-19 Pandemic: Implications and Future Recommendations.
Concepcion J; Yeager M; Alfaro S; Newsome K; Ibrahim J; Bilski T; Elkbuli A
Am Surg; 2023 Jun; 89(6):2276-2283. PubMed ID: 35420510
[TBL] [Abstract][Full Text] [Related]
27. COVID-19 pandemic dynamics in India, the SARS-CoV-2 Delta variant, and implications for vaccination.
Yang W; Shaman J
medRxiv; 2021 Nov; ():. PubMed ID: 34845460
[TBL] [Abstract][Full Text] [Related]
28. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data.
Haas EJ; Angulo FJ; McLaughlin JM; Anis E; Singer SR; Khan F; Brooks N; Smaja M; Mircus G; Pan K; Southern J; Swerdlow DL; Jodar L; Levy Y; Alroy-Preis S
Lancet; 2021 May; 397(10287):1819-1829. PubMed ID: 33964222
[TBL] [Abstract][Full Text] [Related]
29. Excess death among Latino people in California during the COVID-19 pandemic.
Riley AR; Chen YH; Matthay EC; Glymour MM; Torres JM; Fernandez A; Bibbins-Domingo K
medRxiv; 2021 Jan; ():. PubMed ID: 33532794
[TBL] [Abstract][Full Text] [Related]
30. Systematic Review of Excess Mortality in India during the Covid-19 Pandemic with Differentiation between Model-Based and Data-Based Mortality Estimates.
Natarajan S; Subramanian P
Indian J Community Med; 2022; 47(4):491-494. PubMed ID: 36742946
[TBL] [Abstract][Full Text] [Related]
31. The spread in time and space of COVID-19 pandemic waves: the Italian experience from mortality data analyses.
Del Re D; Palla L; Meridiani P; Soffi L; Loiudice MT; Antinozzi M; Cattaruzza MS
Front Public Health; 2024; 12():1324033. PubMed ID: 38481837
[TBL] [Abstract][Full Text] [Related]
32. Effect of influenza vaccine subsidies for older adults on vaccination coverage and mortality before and during the COVID-19 pandemic: an ecological study in Japan.
Ando T; Ibuka Y; Goto R; Haruta J; Le DD; Fujishima S
Public Health; 2023 Nov; 224():152-158. PubMed ID: 37797561
[TBL] [Abstract][Full Text] [Related]
33. Estimating Overall and Cause-Specific Excess Mortality during the COVID-19 Pandemic: Methodological Approaches Compared.
Barbiellini Amidei C; Fedeli U; Gennaro N; Cestari L; Schievano E; Zorzi M; Girardi P; Casotto V
Int J Environ Res Public Health; 2023 May; 20(11):. PubMed ID: 37297545
[TBL] [Abstract][Full Text] [Related]
34. Association between history of HBV vaccine response and anti-SARS-CoV-2 spike antibody response to the BioNTech/Pfizer's BNT162b2 mRNA SARS-CoV-2 vaccine among healthcare workers in Japan: A prospective observational study.
Iwamoto M; Ukimura A; Ogawa T; Kawanishi F; Osaka N; Kubota M; Mori T; Sawamura R; Nishihara M; Suzuki T; Uchiyama K
PLoS One; 2022; 17(5):e0268529. PubMed ID: 35576209
[TBL] [Abstract][Full Text] [Related]
35. Association between mRNA COVID-19 vaccine boosters and mortality in Japan: The VENUS study.
Mimura W; Ishiguro C; Maeda M; Murata F; Fukuda H
Hum Vaccin Immunother; 2024 Dec; 20(1):2350091. PubMed ID: 38757631
[TBL] [Abstract][Full Text] [Related]
36. Adverse events of special interest and mortality following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines in Hong Kong: A retrospective study.
Wong CKH; Lau KTK; Xiong X; Au ICH; Lai FTT; Wan EYF; Chui CSL; Li X; Chan EWY; Gao L; Cheng FWT; Tang SCW; Wong ICK
PLoS Med; 2022 Jun; 19(6):e1004018. PubMed ID: 35727759
[TBL] [Abstract][Full Text] [Related]
37. The mRNA Vaccination Rate Is Negatively and the Proportion of Elderly Individuals Is Positively Associated With the Excess Mortality Rate After 2020 in Japan.
Ato D
Cureus; 2024 Jan; 16(1):e52490. PubMed ID: 38371060
[TBL] [Abstract][Full Text] [Related]
38. COVID-19 mortality and excess mortality among working-age residents in California, USA, by occupational sector: a longitudinal cohort analysis of mortality surveillance data.
Chen YH; Riley AR; Duchowny KA; Aschmann HE; Chen R; Kiang MV; Mooney AC; Stokes AC; Glymour MM; Bibbins-Domingo K
Lancet Public Health; 2022 Sep; 7(9):e744-e753. PubMed ID: 36057273
[TBL] [Abstract][Full Text] [Related]
39. Estimating the impact of the COVID-19 pandemic on diagnosis and survival of five cancers in Chile from 2020 to 2030: a simulation-based analysis.
Ward ZJ; Walbaum M; Walbaum B; Guzman MJ; Jimenez de la Jara J; Nervi B; Atun R
Lancet Oncol; 2021 Oct; 22(10):1427-1437. PubMed ID: 34487693
[TBL] [Abstract][Full Text] [Related]
40. Effectiveness and Waning of Protection With Different SARS-CoV-2 Primary and Booster Vaccines During the Delta Pandemic Wave in 2021 in Hungary (HUN-VE 3 Study).
Vokó Z; Kiss Z; Surján G; Surján O; Barcza Z; Wittmann I; Molnár GA; Nagy D; Müller V; Bogos K; Nagy P; Kenessey I; Wéber A; Polivka L; Pálosi M; Szlávik J; Rokszin G; Müller C; Szekanecz Z; Kásler M
Front Immunol; 2022; 13():919408. PubMed ID: 35935993
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
